# US Transgenic Animals Market

> US Transgenic Animals Market Research Report By Products (Gene Gun, Microinjection) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 10.48%
- **2024:** $ 996.8 Million
- **2025:** $ 1,101.26 Million
- **2035:** $ 2,983.51 Million
- **Key Players:** Heska Corporation (US), Genus plc (GB), AquaBounty Technologies, Inc. (US), Transgene SA (FR), Recombinetics, Inc. (US), InVivo Therapeutics Holdings Corp. (US), Ceres, Inc. (US), Envigo (GB)

**Report ID:** MRFR/LS/18517-HCR · **Pages:** 100 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-transgenic-animals-market-20064

---

## Market Summary

## **US Transgenic Animals Market Overview**

As per MRFR analysis, the US Transgenic Animals Market Size was estimated at 0.88 (USD Billion) in 2023. The US Transgenic Animals Market Industry is expected to grow from 1.08(USD Billion) in 2024 to 3.14 (USD Billion) by 2035. The US Transgenic Animals Market CAGR (growth rate) is expected to be around 10.189% during the forecast period (2025 - 2035).

### **Key US Transgenic Animals Market Trends Highlighted**

The US Transgenic Animals Market is witnessing significant trends driven by advancements in genetic engineering technologies and growing interest in genetically modified organisms (GMOs). Key market drivers include the increasing demand for improved livestock with enhanced traits such as disease resistance, faster growth rates, and better feed conversion efficiency. Regulatory support from the US government, particularly the USDA’s biotechnology regulatory framework, encourages innovation while ensuring animal and food safety. Opportunities lie in biotechnology research for developing transgenic animals that can contribute to food security and sustainability.

For instance, transgenic fish are being explored for aquaculture, presenting a viable alternative for addressing fish shortages. Additionally, as the world faces challenges related to climate change, farmers are looking for stress-resistant animals, opening doors for researchers and companies to invent transgenic solutions that can adapt to varied environmental conditions. Recent trends also showcase rising public acceptance of transgenic animals, especially those that contribute to medical research and pharmaceutical production. The US government has reinforced this trend by facilitating partnerships between public and private sectors to accelerate the development and commercialization of transgenic products.

Another notable trend is the growing investment in precision breeding technologies, which further enhances the ability to create animals with desired traits. The focus on sustainable and ethical practices in animal farming continues to shape consumer preferences, driving the market towards responsible innovations. Overall, the US Transgenic Animals Market is evolving with a strong emphasis on research and regulatory facilitation, creating a dynamic ecosystem for growth.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **US Transgenic Animals Market Drivers**

### **Advancements in Genetic Engineering Techniques**

The US Transgenic Animals Market Industry is experiencing robust growth due to continuous advancements in genetic engineering techniques. Recent innovations in CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology have made it significantly easier and more cost-effective to create transgenic animals, particularly in the biomedical field. According to the National Institute of Health, over the past decade, research funding for genetic engineering has increased by approximately 25%, reflecting the growing interest and potential in this field.

Institutions like Stanford University and MIT are at the forefront, driving Research and Development (R&D) efforts that emphasize the creation of transgenic animals for enhanced disease resistance in livestock and improvement of pharmaceutical production. These advancements are expected to enhance production efficiency and are leading to an expected market expansion, as stakeholders look for innovative solutions to meet food security and public health challenges.

### **Rising Demand for Organ Transplants**

Another significant driver for the US [Transgenic Animals Market](../../../reports/transgenic-animals-market-5464) Industry is the increasing demand for organ transplants. As reported by the United States Department of Health and Human Services, there were over 39,000 organ transplants in the US in 2022 alone, highlighting a 3.5% annual increase in transplant procedures. This growing demand is prompting researchers to explore transgenic animals as potential organ donors. Institutions such as Harvard Medical School have initiated projects involving genetically modified pigs with organs that are more compatible for human transplantation.

The need to alleviate the shortage of available organs is becoming more urgent, thereby propelling market growth for transgenic animal solutions that can provide viable alternatives.

### **Supportive Government Regulations**

The US Transgenic Animals Market Industry is being positively impacted by supportive government regulations that encourage the development and commercialization of transgenic animals. The United States Department of Agriculture (USDA) has made strides in streamlining the regulatory process for genetically modified organisms, allowing for faster approvals and fostering innovation. Recent guidelines published by the USDA indicate the agency's intent to promote biotechnology applications in agriculture.

This regulatory atmosphere is essential for enhancing investment confidence, encouraging private sector participation while providing a framework that ensures safety and efficacy. Such measures are crucial for maintaining public trust and driving forward the adoption of transgenic technologies in agriculture and medicine.

## **US Transgenic Animals Market Segment Insights**

### **Transgenic Animals Market Products Insights**

The Products segment of the US Transgenic Animals Market has emerged as a pivotal area contributing to the advancement of genetic engineering and biotechnology. With applications across various industries including pharmaceuticals, agriculture, and Research and Development (R&D), this market segment plays a vital role in addressing pressing global challenges. Among the various tools utilized for genetic modification, techniques such as Gene Gun and Microinjection stand out due to their specific advantages in the transformation processes of animals.

Gene Gun technology enables the delivery of genetic material into target cells using high-velocity micro-projectiles, facilitating the precise modification of animal genomes. This method is particularly valued for its efficiency and effectiveness in gene transfer, leading to significant enhancements in livestock production traits, disease resistance, and overall animal health. Furthermore, the method is instrumental in generating transgenic models for human disease research, thereby bridging the gap between animal husbandry and biomedical studies.

On the other hand, Microinjection remains a leading technique for introducing foreign DNA directly into fertilized eggs, creating high-quality transgenic animals capable of expressing desired traits. This technology is prominent for its precision and high success rate, allowing researchers to achieve specific genetic alterations that can be inherited in subsequent generations. The significance of Microinjection lies not only in its contributions to the agricultural sector, where it aids in developing transgenic animals with improved performance and sustainability, but also in its role within the biomedical field, promoting advances in disease modeling and therapeutics.

As part of the broader US Transgenic Animals Market landscape, these specifically tailored products provide numerous opportunities for innovation and improvement. The growth of this sector is driven by increasing quests for sustainable agricultural practices and advancements in genetic technology, thus supporting the development of transgenic animals that not only enhance food production efficiency but also contribute to environmental sustainability. While challenges such as regulatory hurdles and public acceptance remain, the potential benefits of these products reinforce their significance within the industry and highlight the importance of continuing research and development efforts in the field.

The ongoing evolution of the US Transgenic Animals Market is indicative of a growing recognition of the transformative powers of genetic technologies, paving the way for a future where transgenic animals play an integral role in meeting both economic and societal needs.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **US Transgenic Animals Market Key Players and Competitive Insights**

The US Transgenic Animals Market is characterized by a dynamic landscape where innovation and technological advancements play pivotal roles in shaping competitive strategies among key players. This market thrives on the potential of genetically modified animals, which hold promises for various applications such as agriculture, pharmaceuticals, and biomedical advancements. The competitive environment is influenced by factors such as regulatory frameworks, consumer acceptance, and the continuous evolution of genetic engineering technologies.

Companies in this market are engaged in extensive research and development to create novel transgenic models that can enhance productivity in livestock, improve disease resistance, and develop biopharmaceuticals, which drives the competition and differentiation among them.

As scientific knowledge progresses, firms are leveraging intellectual property to secure their innovations while also navigating ethical considerations that influence market growth and player strategies. Genus has established a strong presence in the US Transgenic Animals Market through its commitment to providing advanced animal genetics aimed at enhancing livestock productivity. One of the key strengths of Genus lies in its robust research and development capabilities, which enable the company to deliver high-quality genetic solutions in swine and cattle.

The company has a substantial foothold in the market driven by its innovative breeding techniques and successful commercialization of genetically engineered traits that optimize performance and sustainability in agricultural practices.

Genus’s strategic partnerships with research institutions and a focus on improving animal health and welfare further enhance its competitive advantage, solidifying its reputation as a leader in transgenic animal development for various agricultural applications. Hughson Ag distinguishes itself within the US Transgenic Animals Market by focusing on pioneering genetic solutions tailored for improved agricultural productivity. The company markets a diverse portfolio of transgenic animal products including genetically modified livestock designed to enhance disease resistance and yield efficiency.

Hughson Ag's strengths include its innovative approach to genetic engineering, which is supported by a dedicated team of scientists and researchers focused on advancing genetic technologies.

The company has expanded its market presence through strategic mergers and acquisitions aimed at augmenting its R&D capabilities and diversifying its product offerings. By investing in cutting-edge technologies and establishing collaborations with leading research institutions, Hughson Ag continues to position itself as a competitive force in the transgenic animals sector, ultimately aiming to deliver solutions that meet the evolving demands of the US agriculture market.

### **Key Companies in the US Transgenic Animals Market Include**

## **US Transgenic Animals Market Industry Developments**

In the US Transgenic Animals Market, significant developments are shaping the landscape. Notably, AquaBounty Technologies has made strides with its genetically modified salmon, enhancing growth efficiency and addressing food security concerns. Additionally, companies like Genus and Livestock Genetic Innovations are increasingly focused on enhancing livestock productivity and disease resistance through genetic advancements. Recent merger and acquisition activities in this sector include an acquisition by Recombinetics, which expanded its portfolio by acquiring a gene-editing technology firm in March 2023, while ViaGen Pets reported collaboration with Maryland Biotechnology Institute in February 2023 to advance the use of transgenic techniques in pet cloning.

The market has also seen a valuation growth in companies like Horizon Discovery, benefiting from the rising demand for genetic solutions in agriculture and environmental sustainability. The ongoing advancements and regulatory attention toward transgenic technologies in the US are leading to more investments and collaboration among these firms, fostering innovation and responding to consumer demands for sustainable practices. Major happenings over the last couple of years, including Syngenta’s partnerships in biotechnology in June 2021, have further catalyzed growth opportunities within the market, reflecting the dynamic nature of this evolving industry.

## **US Transgenic Animals Market Segmentation Insights**

### **Transgenic Animals Market Products Outlook**

## Market Drivers

### Advancements in Biotechnology

The transgenic animals market is significantly influenced by advancements in biotechnology. Innovations in genetic engineering techniques, such as CRISPR and gene editing, have revolutionized the ability to create transgenic animals with desirable traits. These advancements not only enhance the efficiency of animal breeding but also improve the overall health and productivity of livestock. The market is expected to benefit from these technological developments, with projections indicating a potential market value of $1.8 billion by 2028. As biotechnology continues to evolve, the transgenic animals market is likely to see an influx of new products and applications, further driving its growth and adoption in the agricultural sector.

### Increasing Focus on Food Security

The transgenic animals market is experiencing a notable surge due to the increasing focus on food security in the United States. As the population continues to grow, the demand for sustainable and efficient food production methods becomes paramount. Transgenic animals, engineered for enhanced growth rates and disease resistance, offer a potential solution to meet the rising food demands. According to recent estimates, the market for transgenic animals is projected to reach approximately $1.5 billion by 2027, reflecting a compound annual growth rate (CAGR) of around 8%. This growth is driven by the need for innovative agricultural practices that can ensure a stable food supply, thereby positioning the transgenic animals market as a critical component in addressing food security challenges.

### Investment in Research and Development

Investment in research and development (R&D) is a key driver of growth in the transgenic animals market. Increased funding from both public and private sectors is facilitating the exploration of new genetic modifications that can enhance animal traits. This investment is crucial for advancing the science behind transgenic technologies and ensuring their successful application in agriculture. With R&D expenditures projected to rise by 10% annually, the transgenic animals market is poised for significant advancements. As new discoveries emerge, they are likely to lead to the development of innovative transgenic products, further solidifying the market's position in the agricultural landscape.

### Regulatory Support for Genetic Innovations

The transgenic animals market is benefiting from a supportive regulatory environment that encourages genetic innovations. Regulatory bodies in the United States are increasingly recognizing the potential of transgenic technologies to enhance agricultural productivity and sustainability. This support is crucial for the development and commercialization of transgenic animals, as it provides a framework for safety assessments and approvals. The market is likely to expand as more transgenic products receive regulatory clearance, with estimates suggesting a market growth of around 6% annually. This regulatory backing not only fosters innovation but also instills confidence among consumers and producers in the transgenic animals market.

### Rising Consumer Awareness of Animal Welfare

Consumer awareness regarding animal welfare is increasingly shaping the transgenic animals market. As consumers become more informed about the ethical implications of animal farming, there is a growing demand for livestock that are bred to minimize suffering and enhance health. Transgenic animals, designed to be more resilient to diseases and environmental stresses, align with these consumer preferences. This shift in consumer behavior is expected to influence market dynamics, with a projected increase in demand for ethically produced transgenic livestock. The transgenic animals market may see a growth rate of approximately 7% annually as producers adapt to these changing consumer expectations.

## Future Outlook

The [Transgenic Animals Market](https://www.marketresearchfuture.com/reports/transgenic-animals-market-5464) is projected to grow at a 10.48% CAGR from 2025 to 2035, driven by advancements in biotechnology, increasing demand for genetically modified livestock, and regulatory support.

**New opportunities:**

- Development of precision breeding technologies for enhanced traits
- Expansion of transgenic animal models for biomedical research
- Partnerships with pharmaceutical companies for drug production using transgenic animals

By 2035, the transgenic animals market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Type: Microinjections (Largest) vs. Electroporator (Fastest-Growing)

In the US transgenic animals market, microinjections account for the largest market share among the various methods employed for genetic modifications. This technique is preferred for its precision and effectiveness, allowing for direct introduction of genetic material into the target cells. OCR gene gun technology, while innovative, has a smaller share, as it is often seen as less efficient compared to microinjections and electroporation methods.

Growth trends within this segment show that electroporators are gaining traction as the fastest-growing method due to advancements in technology and the increasing demand for rapid and efficient gene delivery systems. The ability of electroporators to enhance the transfection of tough-to-reach cells makes them increasingly appealing to researchers and companies alike, driving continued investment and development within this area.

Technology: Microinjections (Dominant) vs. Electroporator (Emerging)

Microinjections remain the dominant technology in the US transgenic animals market, primarily due to their established protocols and high success rates in creating transgenic animals. This method enables precise targeting of embryos, which is crucial for ensuring reliable gene expression. On the other hand, electroporation is emerging rapidly, offering a novel approach that uses electrical fields to facilitate gene delivery. This method shows great promise for complex genetic modifications where traditional methods may fall short. The adoption of electroporators is supported by ongoing innovations, making them a valuable alternative in the landscape of gene transfer technologies.

### By Techniques: Retro-virus-mediated transfer of gene (Largest) vs. Microinjection of DNA (Fastest-Growing)

In the US transgenic animals market, retro-virus-mediated transfer of gene holds the largest share due to its widespread application in genetic research and development of transgenic models. This technique is preferred for its efficiency in introducing genetic material into hosts, making it a significant contributor to the overall growth of this market segment. Conversely, embryonic stem-cell-mediated transfer of gene is also notable, though less dominant, reflecting a diversity in techniques available for genetic modifications in animals.

Growth trends indicate an increasing preference for microinjection of DNA, as it is regarded as the fastest-growing method due to advancements in precision and efficiency of gene transfer. Key drivers include rising investments in biotechnology, increasing demand for genetically modified organisms (GMOs), and heightened focus on enhancing livestock productivity. The convergence of technological advancements and regulatory support is expected to further fuel growth in this segment, as it offers researchers and producers innovative ways to enhance genetic traits.

Technique: Retro-virus-mediated transfer of gene (Dominant) vs. Microinjection of DNA (Emerging)

The retro-virus-mediated transfer of gene technique dominates the US transgenic animals market due to its established history and effectiveness in gene transfer applications, making it a preferred choice among researchers. Its robustness and ability to integrate specific genes efficiently into the host genome allow the creation of stable transgenic lines. In comparison, microinjection of DNA is emerging as a significant technique, especially for its precision and potential for rapid development of genetically modified animals. This technique allows for the direct injection of DNA into the zygote, enabling faster turnaround times for generating genetically modified models. Both techniques cater to distinct needs within the research and agricultural sectors, showcasing the evolution of genetic engineering methodologies.

### By Applications: Monoclonal Antibodies (Largest) vs. Xenotransplantation (Fastest-Growing)

The applications in the US transgenic animals market reveal a competitive landscape, with monoclonal antibodies commanding the largest market share. These proteins are instrumental in therapeutic interventions and diagnostics, making them a cornerstone of medical treatments. In contrast, recombinant human proteins also hold a significant share, serving various clinical applications. Xenotransplantation, while currently smaller in market size, shows promising potential as it gains traction, driven by advancements in biotechnology and increased interest in organ transplantation alternatives.

Growth trends in this segment are being propelled by several key drivers. The rising demand for monoclonal antibodies in cancer treatments and autoimmune diseases is fueling market expansion, while innovations in recombinant protein production are enhancing their efficacy. Meanwhile, the interest in xenotransplantation is surging due to the critical shortage of human organs for transplantation, encouraging research and development in genetically modified animals to address this urgent healthcare need.

Monoclonal Antibodies (Dominant) vs. Xenotransplantation (Emerging)

Monoclonal antibodies are a dominant application in the US transgenic animals market, owing to their effectiveness in targeted therapies for cancer and other diseases. These antibodies provide precise therapeutic options, making them essential in modern medicine. Their extensive use in diagnostics further enhances their market presence. On the other hand, xenotransplantation is emerging as a viable solution to combat organ shortages. By utilizing genetically modified animals as organ donors, this approach aims to revolutionize transplant medicine. Although still under research, its potential for addressing critical health needs presents significant opportunities for growth and development in the market.

### By Model Organisms: Rodents (Largest) vs. Fish (Fastest-Growing)

In the US transgenic animals market, the model organisms segment is predominantly represented by rodents, which account for a significant market share due to their extensive use in genetic research and pharmaceutical testing. Fish have also gained a considerable foothold, particularly in aquaculture, making up a smaller but rapidly growing share in this niche. The diversity in model organisms caters to various research needs, leading to a complex but dynamic market landscape.

The growth trends in the model organisms segment are largely driven by advancements in biotechnology and rising investments in genetic research. Rodents continue to dominate due to their established presence and proven effectiveness in studies, while fish are emerging as the fastest-growing due to increasing interest in sustainable practices and their application in food security. These trends reflect a growing shift toward more diverse and innovative research methodologies.

Rodents (Dominant) vs. Fish (Emerging)

Rodents remain the dominant model organism in the US transgenic animals market, favored for their genetic similarity to humans and well-characterized genomes, making them ideal for a range of research applications, including disease modeling and drug development. Their ability to replicate human biological processes enhances their utility in preclinical trials. On the other hand, fish, particularly transgenic species, are becoming an emerging choice due to the increasing focus on environmental sustainability and aquaculture innovations. As researchers seek alternatives that meet nutritional needs with reduced ecological footprints, fish are positioned for growth, offering unique insights into aquatic biology and potential biopharmaceuticals.

### By End-Users: Biotechnological Industry (Largest) vs. Research Organizations (Fastest-Growing)

In the US transgenic animals market, the biotechnological industry holds the largest market share, driven by its extensive application in genetic research and product development. Research organizations also play a critical role, although they currently represent a smaller proportion of the market. Their contributions are essential for continuous innovation and the development of new technologies, which significantly impact market dynamics.

Growth trends within this segment are notably influenced by advancements in genetic engineering and increasing investments in biotechnology research. The expanding interest from academic institutes and research organizations has propelled growth, making them the fastest-growing end-users. Factors such as favorable regulatory frameworks, rising demand for genetically modified organisms, and collaborative ventures between academia and industry further support this upward trend.

Biotechnological Industry (Dominant) vs. Academic Institutes (Emerging)

The biotechnological industry has established itself as a dominant force in the US transgenic animals market due to its robust infrastructure and significant financial backing. This sector focuses on the application of transgenic animals in pharmaceuticals, agriculture, and environmental research, facilitating advancements that propel the industry forward. On the other hand, academic institutes are emerging as key players, engaging in pioneering studies and innovative projects. They often collaborate with biotech firms, bridging the gap between research and practical application. The synergy between these entities enhances knowledge transfer and accelerates technological development, thereby contributing to the overall growth and diversification of the market.

## Competitive Benchmarking

The transgenic animals market is characterized by a dynamic competitive landscape, driven by innovation, regulatory advancements, and increasing demand for genetically modified organisms in agriculture and biomedical research. Key players such as AquaBounty Technologies, Inc. (US), Heska Corporation (US), and Recombinetics, Inc. (US) are at the forefront, each adopting distinct strategies to enhance their market positioning. AquaBounty Technologies, for instance, focuses on the development of genetically modified salmon, which has gained traction due to its potential to meet rising global protein demands while addressing sustainability concerns. Meanwhile, Heska Corporation emphasizes innovation in veterinary diagnostics and therapeutics, leveraging transgenic technologies to improve animal health outcomes. Recombinetics, Inc. is strategically positioned in the livestock sector, utilizing gene editing to enhance traits in agricultural animals, thereby contributing to food security and efficiency in production.The business tactics employed by these companies reflect a concerted effort to optimize supply chains and localize manufacturing processes. The market structure appears moderately fragmented, with several players vying for dominance while also collaborating on research initiatives. This collective influence of key players fosters a competitive environment that encourages innovation and the rapid adoption of new technologies, ultimately benefiting the industry as a whole.

In October  AquaBounty Technologies, Inc. (US) announced the successful completion of a major expansion of its production facility in Indiana, aimed at increasing the output of its genetically modified salmon. This strategic move is significant as it not only enhances production capacity but also positions the company to better meet the growing demand for sustainable seafood, aligning with global trends towards environmentally friendly food sources. The expansion is expected to bolster AquaBounty's market share and reinforce its leadership in the aquaculture sector.

In September  Heska Corporation (US) launched a new line of transgenic diagnostic tools designed to improve the detection of genetic disorders in pets. This initiative underscores the company's commitment to innovation in veterinary care, potentially transforming how genetic conditions are diagnosed and treated in companion animals. By enhancing its product offerings, Heska aims to solidify its position as a leader in veterinary diagnostics, catering to the increasing demand for advanced healthcare solutions in the pet industry.

In August  Recombinetics, Inc. (US) entered into a strategic partnership with a leading agricultural biotechnology firm to develop gene-edited livestock with enhanced disease resistance. This collaboration is pivotal as it combines expertise from both companies, potentially accelerating the development of innovative solutions that address critical challenges in livestock management. The partnership reflects a broader trend towards collaboration in the industry, where shared knowledge and resources can lead to significant advancements in transgenic technologies.

As of November  the transgenic animals market is witnessing trends that emphasize digitalization, sustainability, and the integration of artificial intelligence in research and development processes. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise to drive innovation. Looking ahead, it is likely that competitive differentiation will evolve, shifting from traditional price-based competition to a focus on technological advancements, innovation, and supply chain reliability. This transition may redefine how companies position themselves in the market, ultimately fostering a more sustainable and efficient transgenic animals industry.

## Recent News & Developments

In the US Transgenic Animals Market, significant developments are shaping the landscape. Notably, AquaBounty Technologies has made strides with its genetically modified salmon, enhancing growth efficiency and addressing food security concerns. Additionally, companies like Genus and Livestock Genetic Innovations are increasingly focused on enhancing livestock productivity and disease resistance through genetic advancements. Recent merger and acquisition activities in this sector include an acquisition by Recombinetics, which expanded its portfolio by acquiring a gene-editing technology firm in March 2023, while ViaGen Pets reported collaboration with Maryland Biotechnology Institute in February 2023 to advance the use of transgenic techniques in pet cloning.

The market has also seen a valuation growth in companies like Horizon Discovery, benefiting from the rising demand for genetic solutions in agriculture and environmental sustainability. The ongoing advancements and regulatory attention toward transgenic technologies in the US are leading to more investments and collaboration among these firms, fostering innovation and responding to consumer demands for sustainable practices. Major happenings over the last couple of years, including Syngenta’s partnerships in biotechnology in June 2021, have further catalyzed growth opportunities within the market, reflecting the dynamic nature of this evolving industry.

## Report Scope

| MARKET SIZE 2024 | 996.8(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 1101.26(USD Million) |
| MARKET SIZE 2035 | 2983.51(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 10.48% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Heska Corporation (US), Genus plc (GB), AquaBounty Technologies, Inc. (US), Transgene SA (FR), Recombinetics, Inc. (US), InVivo Therapeutics Holdings Corp. (US), Ceres, Inc. (US), Envigo (GB) |
| Segments Covered | Type, Techniques, Applications, Model Organisms, End-Users |
| Key Market Opportunities | Advancements in genetic engineering techniques enhance potential for transgenic animals in agriculture and biomedical research. |
| Key Market Dynamics | Regulatory advancements and technological innovations drive growth in the transgenic animals market. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What is the current valuation of the US transgenic animals market?**
A: The market valuation was $996.8 Million in 2024.

**Q: What is the projected market size for the US transgenic animals market by 2035?**
A: The projected valuation for 2035 is $2983.51 Million.

**Q: What is the expected CAGR for the US transgenic animals market during the forecast period 2025 - 2035?**
A: The expected CAGR is 10.48%.

**Q: Which companies are considered key players in the US transgenic animals market?**
A: Key players include Heska Corporation, Genus plc, AquaBounty Technologies, Inc., and Recombinetics, Inc.

**Q: What are the main types of techniques used in the US transgenic animals market?**
A: Techniques include OCR gene gun, microinjections, and electroporators.

**Q: What is the market valuation for microinjections in the US transgenic animals market?**
A: The market valuation for microinjections was $400.0 Million in 2024 and is projected to reach $1200.0 Million.

**Q: What applications are driving growth in the US transgenic animals market?**
A: Applications include recombinant human proteins, monoclonal antibodies, and xenotransplantation.

**Q: What is the market size for model organisms in the US transgenic animals market?**
A: The market size for model organisms was $300.0 Million for mice and is projected to reach $900.0 Million.

**Q: Which end-users are primarily involved in the US transgenic animals market?**
A: End-users include the biotechnological industry, research organizations, and academic institutes.

**Q: What is the market valuation for xenotransplantation applications in the US transgenic animals market?**
A: The market valuation for xenotransplantation applications was $496.8 Million in 2024 and is expected to reach $1483.51 Million.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-transgenic-animals-market-20064*